Cite
CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer.
MLA
Tomohiko Sakabe, et al. “CD117 Expression Is a Predictive Marker for Poor Prognosis in Patients with Non-Small Cell Lung Cancer.” Oncology Letters, vol. 13, no. 5, May 2017, pp. 3703–08. EBSCOhost, https://doi.org/10.3892/ol.2017.5925.
APA
Tomohiko Sakabe, Junya Azumi, Tomohiro Haruki, Yoshihisa Umekita, Hiroshige Nakamura, & Goshi Shiota. (2017). CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer. Oncology Letters, 13(5), 3703–3708. https://doi.org/10.3892/ol.2017.5925
Chicago
Tomohiko Sakabe, Junya Azumi, Tomohiro Haruki, Yoshihisa Umekita, Hiroshige Nakamura, and Goshi Shiota. 2017. “CD117 Expression Is a Predictive Marker for Poor Prognosis in Patients with Non-Small Cell Lung Cancer.” Oncology Letters 13 (5): 3703–8. doi:10.3892/ol.2017.5925.